Click here for more details about the global planning of Taiwan new drug R&S and clinical trials
BioIPSeeds creates a new model for academia-industry interaction by providing an effective, safe and trustful environment.
TRPMA News
-
Taiwan: TRPMA and DTCO Jointly Announce the Development of “TRPMA Biopharma Trusted Platform”
Read More
Taiwan: TRPMA and DTCO Jointly Announce the Development of “TRPMA Biopharma Trusted Platform”
(Source: TRPMA 2016-05-10）
Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA) announced the collaboration with Digital Treasury Corporation (DTCO) to jointly develop the “TRPMA Biopharma Trusted Platform”, an application of the latest Blockchain Technology.
Welcome to TRPMA website
Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), composed of 28 Taiwanese innovative biopharmaceutical companies, plays a pivotal role in coordinating the resources, strengthening alliances among the industry, the academic and the government in Taiwan. TRPMA members aim to create a competitive value chain of biopharmaceutical industry to boost the nation's economy and promote the Asian and global cooperation in biopharmaceutical innovation.
Industry News
-
Singapore: EU Parliament gives green light to EU-Singapore trade and investment protection deals
Read More
Parliament endorsed the free trade and investment protection deals between EU and Singapore, serving as blueprint for further cooperation with Southeast Asia.
-
US: CBER guidance on gene therapies – what to expect in 2019
Read More
The US Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) on Wednesday released plans for what guidance is to be expected in 2019, including six final guidance documents related to gene therapies.
-
US: FDA finalizes guidance on regenerative medicines expedited programs
Read More
With almost 80 regenerative medicine advanced therapy (RMAT) designation requests in 2017 and 2018, it’s clear that the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has been busy with RMATs, though only on Friday did the agency finalize guidance from 2017 on the designation.
International Conference
BioIPSeeds Trusted Platform
TRPMA Brochure
TRPMA Members
|
|||||||||||||||||||||||||||
